Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi) - Concepedia

Concepedia

Publication | Closed Access

Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)

74

Citations

26

References

2018

Year

Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, Ludmila Fridel, Tzippy Shochat, Laila C. Roisman, Maya Ilouze, Anna Belilovski Rozenblum, Smadar Geva, Alona Zer,

MedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorImmune Check-point InhibitorsRare Targetable DriversCancer TreatmentImmunotherapyOncologyLung Cancer

References

	Year	Citations

Page 1

Page 1